In particular, the 0.2‐ and 1‐μg/mL PF4 groups exhibited a significant decrease in the relative expression of RUNX2, SP7, and SPARC compared with that in the OM and PF4 + heparin groups. The gene discussed is PF4; the disease is ocular melanoma.